Drug Interactions between BromSite and gatifloxacin
This report displays the potential drug interactions for the following 2 drugs:
- BromSite (bromfenac ophthalmic)
- gatifloxacin
Interactions between your drugs
No interactions were found between BromSite and gatifloxacin. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
BromSite
A total of 74 drugs are known to interact with BromSite.
- Bromsite is in the drug class ophthalmic anti-inflammatory agents.
- Bromsite is used to treat Postoperative Ocular Inflammation.
gatifloxacin
A total of 501 drugs are known to interact with gatifloxacin.
- Gatifloxacin is in the drug class quinolones and fluoroquinolones.
- Gatifloxacin is used to treat the following conditions:
Drug and food interactions
gatifloxacin food
Applies to: gatifloxacin
Concurrent ingestion of calcium-fortified foods (i.e., cereal, orange juice) may alter the bioavailability of gatifloxacin. The mechanism is chelation of calcium and the quinolone, resulting in decreased bioavailability. In the case of orange juice, inhibition of intestinal transport mechanisms (P-glycoprotein or organic anion-transporting polypeptides) by flavones may also be involved. Data have been conflicting: One study has reported no effect with milk coadministration. Another study reported a modest decrease in gatifloxacin bioavailability (13.5% decrease in Cmax,12% decrease in AUC, 15% increase in total clearance) when taken with 12 ounces of calcium-fortified orange juice instead of water, which could be clinically significant if the infecting organisms have borderline susceptibilities. The manufacturer states that gatifloxacin may be taken without regard to food, milk, or calcium. Clinicians should be aware of the possibility of an interaction if subtherapeutic effects are observed.
References (2)
- (2001) "Product Information. Tequin (gatifloxacin)." Bristol-Myers Squibb
- Wallace AW, Victory JM, Amsden GW (2003) "Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers." J Clin Pharmacol, 43, p. 92-6
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.